State Street SPDR S&P Biotech ETF
Twelve months
- Assets under management
- $12.0B
- Expense ratio
- 0.35%
- Holdings
- 155
- NAV
- $168.23
- Inception
- Jan 31, 2006
- Issuer
- SPDR
- Asset class
- Equity
- Exchange
- —
- Average volume
- 8.8M
- Volume
- —
- 50-day average
- —
- 200-day average
- —
- Day range
- —
- Previous close
- —
- Domicile
- US
- Official page
- ssga.com
About this fund
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
Sector exposure
- Healthcare99.60%
- Financial Services0.40%
Top holdings
Largest positions by weight. Each links to its own stock page.
- 1MRNAMODERNA INC2.76%
- 2TWSTTWIST BIOSCIENCE CORP2.01%
- 3APGEAPOGEE THERAPEUTICS INC1.45%
- 4NTRANATERA INC1.39%
- 5KYMRKYMERA THERAPEUTICS INC1.37%
- 6RVMDREVOLUTION MEDICINES INC1.36%
- 7PRAXPRAXIS PRECISION MEDICINES I1.36%
- 8HALOHALOZYME THERAPEUTICS INC1.35%
- 9ORKAORUKA THERAPEUTICS INC1.34%
- 10DNTHDIANTHUS THERAPEUTICS INC1.30%
- 11ERASERASCA INC1.30%
- 12TVTXTRAVERE THERAPEUTICS INC1.28%
- 13CGONCG ONCOLOGY INC1.28%
- 14PTGXPROTAGONIST THERAPEUTICS INC1.26%
- 15PCVXVAXCYTE INC1.20%
- 16SRRKSCHOLAR ROCK HOLDING CORP1.19%
- 17REGNREGENERON PHARMACEUTICALS1.19%
- 18ROIVROIVANT SCIENCES LTD1.18%
- 19SLSSELLAS LIFE SCIENCES GROUP I1.17%
- 20INSMINSMED INC1.17%
- 21RYTMRHYTHM PHARMACEUTICALS INC1.17%
- 22AMGNAMGEN INC1.15%
- 23VRTXVERTEX PHARMACEUTICALS INC1.12%
- 24ARWRARROWHEAD PHARMACEUTICALS IN1.11%
- 25SYRESPYRE THERAPEUTICS INC1.11%
Similar funds
All ETFs →Questions
What does XBI hold?
XBI is State Street SPDR S&P Biotech ETF, run by SPDR and listed in the US. It currently holds 155 positions; the largest are MRNA, TWST, APGE.
What is the expense ratio of XBI?
XBI charges 0.35% per year. The fee is taken out of the fund's assets, so it shows up as a small drag on performance rather than as a separate bill.
How large is XBI?
The fund manages $12.0B. Size matters mainly for liquidity: larger funds tend to trade with tighter spreads and are less likely to be closed by the issuer.
How do I research what is inside XBI?
The holdings list on this page links every position to its own Plutux stock page, where you get the company's price history, financials and AI analysis.
Market data is provided for information only and is not investment advice. Figures can be delayed or restated by the data provider.
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer